+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07835360

Observational Study on Body Composition Changes After Starting GLP-1 Receptor Agonists in Adults with Obesity or Type 2 Diabetes in Real-World Settings

Led by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Updated on 2026-09-25

200

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying adults with obesity andor type 2 diabetes who start treatment with GLP-1 receptor agonist medications, which are approved for weight loss and blood sugar control. The study aims to understand how muscle and fat in the body change over about one year after starting these medications, focusing on the quality of weight loss and its impact on strength and daily function. This is an observational study following patients under real-world medical care without assigning treatments. Participants will be adults beginning or adjusting doses of GLP-1 receptor agonists as part of their usual care. They will be followed for 52 weeks with visits at baseline, 24 weeks, and 52 weeks, plus a phone check-in at 12 weeks. Assessments include body composition scans using DXA, grip strength, walking speed, physical performance tests, blood tests, and questionnaires on diet and physical activity. Some participants may opt to provide an extra blood sample for genetic testing. During the study, participants will have body composition measured, physical function tested, and blood samples collected to track changes in muscle, fat, metabolic markers, and other health indicators. The study also monitors treatment adherence and changes in medication use. Data are collected at two centers in Mexico using secure electronic systems to protect confidentiality. The study does not involve experimental drugs, randomization, or additional costs to participants.

CONDITIONS

Brief Title

Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here